Bess Royalty and SWK Funding are expected to pay an additional $1 million to InSite if Besivance sales goals are met by February 2014.
Besivance has been FDA approved since 2009 and is sold worldwide by Bausch + Lomb.
More Articles on Ophthalmology:
Devers Eye Institute Offers Corneal Crosslinking
Dr. Mary Green Honored as Sightpath Top Surgeon
IRIDEX, Peregrine Surgical Partner
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
